NxStage: Entry Into A Material Definitive Agreement
The following excerpt is from the company's SEC filing.
NxStage Medical, Inc. (“NxStage”) and Fresenius USA Marketing, Inc. (“Fresenius”) are parties to a Chronic Outpatient Therapy Agreement dated as of November 24, 2009 (as amended, the “Fresenius Agreement”) pursuant to which Fresenius purchases the NxStage® System OneTM and related supplies for home hemodialysis therapy in the United States. On January 10, 2014, NxStage and Fresenius amended the Fresenius Agreement, effective as of January 1, 2014, to extend its term through December 31, 2016, with monthly renewals thereafter unless terminated by either party with 30 days’ prior notice.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever NxStage Medical
makes a similar move, sign up!